Identifying priority countries for scaling up small-quantity lipid-based nutrient supplements

Navideh Noori1, Christine P Stewart2, Christine M McDonald2,3

  • 1Institute for Disease Modeling, Gates Foundation, Seattle, Washington, USA Navideh.Noori@gatesfoundation.org.

BMJ Global Health
|December 11, 2025
PubMed

Insights

Small-quantity lipid-based nutrient supplements (SQ-LNS) can prevent child malnutrition and mortality. Scaling up SQ-LNS in high-burden countries, primarily in Sub-Saharan Africa, is crucial to address the global nutrition crisis.

Area of Science:

  • Global Health
  • Nutritional Science
  • Pediatric Health

Background:

  • Undernutrition causes nearly half of deaths in children under 5 globally.
  • Small-quantity lipid-based nutrient supplements (SQ-LNS) are proven to prevent wasting, stunting, anemia, and mortality in children aged 6-23 months in low- and middle-income countries (LMICs).
  • The current global food insecurity and nutrition crisis necessitates urgent scale-up of effective preventive interventions like SQ-LNS.

Purpose of the Study:

  • To identify countries with the highest burden of child wasting, stunting, and mortality to prioritize SQ-LNS scale-up.
  • To assess the potential impact of SQ-LNS on child mortality, stunting, and wasting using a care cascade model.
  • To identify high-burden subnational regions within the top 20 countries for targeted interventions.

Main Methods:

  • Analysis of national survey data (Demographic and Health Survey, Multiple Indicator Cluster Surveys) and the Lives Saved Tool to identify countries with the highest child malnutrition and mortality burdens.
  • Application of a care cascade model using national-level estimates to project the impact of SQ-LNS.
  • Subnational analysis in the 20 highest-burden countries using the most recent available survey data.

Main Results:

  • The top 20 countries with the highest burden of child wasting, stunting, and mortality were identified, with many located in Sub-Saharan Africa and some in South/Southeast Asia.
  • Some identified countries had survey data older than 10 years, highlighting potential data gaps.
  • The care cascade model indicated that widespread provision of SQ-LNS could avert a substantial number of stunting and wasting cases and deaths.
  • Several high-burden countries also face significant acute food insecurity.

Conclusions:

  • The majority of the top 20 countries are concentrated in Sub-Saharan Africa, with others in South and Southeast Asia.
  • This geographical clustering emphasizes the critical need for focused interventions in these regions to combat child malnutrition.
  • Targeted scale-up of SQ-LNS in these high-burden areas presents a significant opportunity to reduce child mortality and morbidity.
Abstract

Related Concept Videos

Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.8K
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
197
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
176
Lipid Absorption01:24

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.4K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
198
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
152